These results clearly show that ADC and Alzheimer's disease are characterized by distinct CSF tau and amyloid biomarker patterns suggesting distinct pathogenetic processes underlying the two conditions. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.